Product Description
Against this background, the mHealth App Performance Benchmarking 2013 report brings transparency about the mHealth app market opportunity.
The 170 pages report provides answers for the following questions:
– Downloads: What are the average monthly and total lifetime downloads of top free and paid mhealth apps per country?
– Countries: Which country offers the highest download potential for mHealth apps?
– Business model: What are the performance differences between paid and free apps per platform and country?
– Pricing: What are the pricing differences amongst top 5 countries for most successful mHealth apps?
– Platform: Which is the best mobile platform (iPhone, iPad and Android) to publish free or paid mHealth apps in each country?
– mHealth app categories: How big are the performance differences between apps that are listed in the Health&Fitness and Medical category
– Multi-platform publishing: What are the chances to get into the top ranks on more than one platform in each country?
– Lifetime: How long do successful mHealth apps stay in the app market per country?
– App sub-categories: Which mHealth sub-categories are most successful per country and platform?
Benefits:
Readers of the report will …
– … gain detailed performance statistics for top performing mHealth apps in selected countries and platforms to support any mHealth app business plan
– … learn about market differences (regional, OS-platforms, monetization, etc.) to support any market entry strategy
– … gain a deep understanding on how many users could be reached with an mHealth app today in each country
Who is it for?
The mHealth App Performance Benchmarking 2013 report is a factbase for mHealth app publishers from traditional healthcare or pharma companies, new entrants as well as Telecom companies. It also addresses VCs and consultants to evaluate mHealth app opportunities.
Methodology:
The report is based on an analysis of the 795 most successful apps of the Health&Fitness and Medical app categories within 5 countries. The analysis was conducted between Dec. 2012 and Feb. 2013.